Giving DM a chance until mid-Feb '24Well, the lack of meaningful (costed) NRs has certainly been an important disappointment, to me, throughout 2023.
I never really expected much from the health and EV and appreciate AnalyticsGPT will need time to gain traction - especially given the increasingly competitive landscape.
Where I'm most disappointed is in the lack of newd regarding the $40M Nexalogy project - no visibily on income, neither through NRs nor in quarterlies - as well as in the lack of any traction regarding South Korea initiatives which have been ongoing for years and shoukd, IMO, have generated more contracts by now.
I opted to add another 140,000 at 0.55 yesterday but, unless DM shows the goods by mid-Feb 2024, I'm highly likely to cut my losses and move on.